William Blair & Company
TRHC

William Blair & Company’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

William Blair & Company’s Portfolio TRHC Stock Details TRHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,497
Closed -$66.8K – 1863
2022
Q4 		$66.8K Sell
13,497
-1,860
-12% -$7.66K ﹤0.01% 1539
2022
Q3 		$74K Sell
15,357
-923
-6% -$3.96K ﹤0.01% 1547
2022
Q2 		$42K Sell
16,280
-1,148
-7% -$4.31K ﹤0.01% 1648
2022
Q1 		$100K Sell
17,428
-2,307
-12% -$20.7K ﹤0.01% 1636
2021
Q4 		$296K Sell
19,735
-84,791
-81% -$1.54M ﹤0.01% 1428
2021
Q3 		$2.74M Buy
104,526
+7,025
+7% +$259K 0.01% 617
2021
Q2 		$4.88M Buy
97,501
+6,173
+7% +$276K 0.02% 464
2021
Q1 		$4.21M Buy
91,328
+15,702
+21% +$749K 0.02% 489
2020
Q4 		$3.24M Sell
75,626
-9,737
-11% -$370K 0.01% 534
2020
Q3 		$3.48M Buy
85,363
+448
+0.5% +$22.3K 0.01% 469
2020
Q2 		$4.65M Buy
84,915
+2,245
+3% +$128K 0.02% 393
2020
Q1 		$4.32M Buy
82,670
+1,563
+2% +$84.6K 0.03% 360
2019
Q4 		$3.95M Buy
81,107
+3,219
+4% +$151K 0.02% 443
2019
Q3 		$4.28M Buy
77,888
+272
+0.4% +$15.6K 0.02% 399
2019
Q2 		$3.88M Buy
+77,616
New +$3.86M 0.02% 427
2019
Q1 		– Sell
-4,650
Closed -$296K – 1745
2018
Q4 		$296K Sell
4,650
-10,300
-69% -$729K ﹤0.01% 1086
2018
Q3 		$1.21M Sell
14,950
-25,475
-63% -$1.87M 0.01% 681
2018
Q2 		$2.58M Sell
40,425
-3,400
-8% -$167K 0.02% 501
2018
Q1 		$1.7M Buy
43,825
+24,625
+128% +$863K 0.01% 588
2017
Q4 		$539K Buy
+19,200
New +$563K ﹤0.01% 933

Other funds holding TRHC

ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
RP
Repertoire Partners New York $143M AUM 28.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair & Company's TRHC Position: Q1 2023 in Review

William Blair & Company sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q1 2023, closing a stake of 13,497 shares — an estimated $66.8K sold.

William Blair & Company first reported a position in TRHC in Q4 2017 and held it in 20 quarters. The position peaked at $4.88M in Q2 2021. 62 funds tracked by Wall St. Rank hold TRHC as of Q1 2023.

  • William Blair & Company reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • William Blair & Company sold 13,497 Tabula Rasa HealthCare, Inc. Common Stock shares in Q1 2023, an estimated $66.8K.
  • William Blair & Company first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q4 2017 and held it in 20 quarters.
  • William Blair & Company's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $4.88M in Q2 2021.
  • 62 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q1 2023.

Based on William Blair & Company's 13F filing for Q1 2023, filed 12 May 2023.